RenovoRx RNXT
NASDAQ RNXT
$1.32 +0.00 (+0.00%)
As of: Aug 21, 2026 · 3:58 PM EDT

RenovoRx (RNXT) EBT Margin (QoQ) (2025 - 2026)

RenovoRx (RNXT) EBT Margin (QoQ) (2025 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 RenovoRx 62.20 Mn 62.20 Mn 766,000.00

Historic Data

Download Data
DateValue
Jun 30, 2026 23,633.00
Mar 31, 2026 86,140.00
Dec 31, 2025 4,682.00
Sep 30, 2025 -65,773.00
Jun 30, 2025 86,962.00